| The adoption of form postponement strategy in a global logistics system: the case of Taiwanese information technology industry JS Chiou, LY Wu, JC Hsu Journal of Business Logistics 23 (1), 107-124, 2002 | 102 | 2002 |
| Trend and geographic analysis of the prevalence of dengue in Taiwan, 2010–2015 JC Hsu, CL Hsieh, CY Lu International Journal of Infectious Diseases 54, 43-49, 2017 | 53 | 2017 |
| Insecticide susceptibility of cabbage flea beetle (Phyllotreta striolata (Fab.)) in Taiwan. HT Feng, YJ Huang, JC Hsu Plant Protection Bulletin (Taipei) 42 (1), 67-72, 2000 | 45 | 2000 |
| 10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan’s National Health Insurance Research Database HC Hsieh, JC Hsu, CY Lu BMJ open 7 (5), e014150, 2017 | 41 | 2017 |
| The evolution of Taiwan’s National Health Insurance drug reimbursement scheme JC Hsu, CY Lu DARU Journal of Pharmaceutical Sciences 23, 1-7, 2015 | 41 | 2015 |
| Disease and economic burden for rare diseases in Taiwan: a longitudinal study using Taiwan’s National Health Insurance Research Database JC Hsu, HC Wu, WC Feng, CH Chou, ECC Lai, CY Lu PLoS One 13 (9), e0204206, 2018 | 32 | 2018 |
| Net clinical benefit of oral anticoagulants: a multiple criteria decision analysis JC Hsu, CY Hsieh, YHK Yang, CY Lu PloS one 10 (4), e0124806, 2015 | 32 | 2015 |
| Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study JC Hsu, CY Lu, AK Wagner, KA Chan, MS Lai, D Ross-Degnan Health Policy 116 (2-3), 196-205, 2014 | 26 | 2014 |
| Comprehensive value assessment of drugs using a multi-criteria decision analysis: an example of targeted therapies for metastatic colorectal cancer treatment JC Hsu, JY Lin, PC Lin, YC Lee PloS one 14 (12), e0225938, 2019 | 22 | 2019 |
| Longitudinal trends in use and costs of targeted therapies for common cancers in Taiwan: a retrospective observational study JC Hsu, CY Lu BMJ open 6 (6), e011322, 2016 | 21 | 2016 |
| Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study JC Hsu, CF Wei, SC Yang, PC Lin, YC Lee, CY Lu BMJ open 10 (5), e033427, 2020 | 19 | 2020 |
| Botulinum toxin injections for treatment of drooling in children with cerebral palsy: A systematic review and meta-analysis SA Hung, CL Liao, WP Lin, JC Hsu, YH Guo, YC Lin Children 8 (12), 1089, 2021 | 16 | 2021 |
| Effectiveness of technology transfer measures in improving SME productivity: An empirical study of Taiwan J Hsu The Journal of American Academy of Business 15 (2), 206-211, 2010 | 16 | 2010 |
| Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan JC Hsu, JY Lin, MY Hsu, PC Lin PLoS One 13 (8), e0202725, 2018 | 15 | 2018 |
| Risk–benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis JC Hsu, DH Tang, CY Lu International Journal of Clinical Practice 69 (4), 436-443, 2015 | 15 | 2015 |
| Association between social media use and cancer screening awareness and behavior for people without a cancer diagnosis: Matched cohort study L Qin, X Zhang, A Wu, JS Miser, YL Liu, JC Hsu, BC Shia, L Ye Journal of medical Internet research 23 (8), e26395, 2021 | 12 | 2021 |
| Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study JC Hsu, CF Wei, SC Yang BMJ open 9 (3), e022293, 2019 | 12 | 2019 |
| Use of assisted reproductive technologies before and after the Artificial Reproduction Act in Taiwan JC Hsu, YC Su, BY Tang, CY Lu PloS one 13 (11), e0206208, 2018 | 12 | 2018 |
| How Did Multiple FDA actions affect the utilization and reimbursed costs of thiazolidinediones in US medicaid? JC Hsu, D Ross-Degnan, AK Wagner, F Zhang, CY Lu Clinical therapeutics 37 (7), 1420-1432. e1, 2015 | 12 | 2015 |
| Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: analysis of real-world data in a tertiary hospital in Taiwan SC Yang, WW Lai, JC Hsu, WC Su, JD Wang PLoS One 15 (4), e0231413, 2020 | 11 | 2020 |
Christine Y. LuAssociate Professor, Harvard Medical School and Harvard Pilgrim Health Care InstituteVerified email at harvardpilgrim.org
